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Abstract
The last decade has seen rapid evolution in guidance from the WHO concerning the provision of
HIV services along the diagnosis-to-treatment continuum, but the extent to which these recommen-
dations are adopted as national policies in Kenya, and subsequently implemented in health facili-
ties, is not well understood. Identifying gaps in policy coverage and implementation is important
for highlighting areas for improving service delivery, leading to better health outcomes. We com-
pared WHO guidance with national policies for HIV testing and counselling, prevention of mother-
to-child transmission, HIV treatment and retention in care. We then investigated implementation of
these national policies in health facilities in one rural (Kisumu) and one urban (Nairobi) sites in
Kenya. Implementation was documented using structured questionnaires that were administered
to in-charge staff at 10 health facilities in Nairobi and 34 in Kisumu. Policies were defined as widely
implemented if they were reported to occur in> 70% facilities, partially implemented if reported to
occur in 30–70% facilities, and having limited implementation if reported to occur in< 30% facili-
ties. Overall, Kenyan national HIV care and treatment policies were well aligned with WHO guid-
ance. Policies promoting access to treatment and retention in care were widely implemented, but
there was partial or limited implementation of several policies promoting access to HIV testing,
and the more recent policy of Option Bþ for HIV-positive pregnant women. Efforts are needed to
improve implementation of policies designed to increase rates of diagnosis, thus facilitating entry
into HIV care, if morbidity and mortality burdens are to be further reduced in Kenya, and as the
country moves towards universal access to antiretroviral therapy.
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Introduction
Over the last 10–15 years, the provision and uptake of HIV testing
services has increased dramatically in sub-Saharan Africa, as has the
number of people living with HIV (PLHIV) who are receiving anti-
retroviral therapy (ART). Despite this, rates of HIV testing remain
sub-optimal in many countries (Venkatesh et al. 2011; Baggaley
et al. 2012; Cawley et al. 2013). In addition, data on viral load
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monitoring among treated patients are sparse, yet viral load suppres-
sion is important in terms of not only individual patient outcomes
but also ‘treatment as prevention’ and meeting UNAIDS ‘90-90-90’
targets (UNAIDS 2014b). Furthermore, higher rates of mortality
persist among PLHIV compared with non-infected men and women
(Reniers et al. 2014), largely due to high rates of attrition across the
HIV care continuum before long-term adherence to treatment
(Rosen and Fox 2011; Kilmarx and Mutasa-Apollo 2012; Kranzer
et al. 2012; Bor et al. 2015). The WHO regularly releases clinical
and programmatic guidance on the provision of HIV services,
including recent recommendations for a universal ‘test and treat’ ap-
proach (World Health Organisation 2015). However, the adoption
of such recommendations within national HIV care and treatment
policies is influenced by contextual factors operating within eco-
nomic, political and social spheres (Hanney et al. 2003; Parkhurst
and Lush 2004; Theobald et al. 2011; Edwards and Barker 2014),
and multi-country studies have shown considerable heterogeneity in
terms of which HIV care and treatment policies are adopted and
when (Nelson et al. 2014; Kathryn Church et al. 2015).
In Kenya, the HIV epidemic can be described as generalised
within the mainstream population, but also concentrated in most-at-
risk populations (MARPs) such as men who have sex with men
(MSM), commercial sex workers (CSW) and injecting drug users
(IDU) (National AIDS Control Council 2014a,b). The National
AIDS Control Council, the body responsible for coordinating the
HIV response in Kenya, has developed a number of National
Strategic Plans that detail priority interventions to tackle the HIV
epidemic (National AIDS Control Council 2009; 2014b). These in-
clude interventions to improve the timely identification and linkage
to care of PLHIV, as well as interventions to increase coverage of
care and treatment, with a particular focus on reducing loss across
the diagnosis-to-treatment continuum and on improving health out-
comes. However, evidence on the translation of international guide-
lines and national-level HIV policies into practice at the health
facility level is limited despite the fact that facility-level practices
will influence health outcomes through various pathways including
service access and coverage, quality of care, coordination of care
and patient tracking, support to PLHIV and medical management
(Mills et al. 2011; Wilson et al. 2014). Understanding HIV policy
gaps relative to WHO recommendations, as well as contradictions
between national level policy and practice, would be useful for
policymakers concerned with improving HIV service delivery
(Hirschhorn et al. 2007).
In this article, we compare the national HIV policy profile in
Kenya with WHO policy guidance relating to HIV testing, preven-
tion of mother-to-child transmission (PMTCT), and HIV care and
treatment. We furthermore assess the extent to which Kenyan na-
tional HIV policies are implemented in health facilities serving the
populations of an urban health and demographic surveillance site
(HDSS) in Nairobi and a rural HDSS in Kisumu.
Materials and methods
Study setting
Nairobi is Kenya’s capital city with a fast-growing population, a
large proportion of whom live below the poverty line in urban
slums. The Nairobi Urban Health and Demographic Surveillance
System (NUHDSS) was set up in 2002 in order to investigate the
long-term social, economic and health consequences of urban resi-
dence among a population of about 120 000 people in two slum
communities (Korogocho and Viwandani) (Beguy et al. 2015).
HIV prevalence among adults aged 15–64 years in the Nairobi
HDSS was most recently estimated at 12% in 2007 (Madise et al.
2012). The Kisumu Health and Demographic Surveillance System
(KEMRI/CDC HDSS) is located in Rarieda, Siaya and Gem Districts
in Nyanza province in Western Kenya and covers a combined popu-
lation of about 220 000 people. Over 95% of the population are
members of the Luo tribe and subsistence farming and fishing are
the mainstay of the local economy (Odhiambo et al. 2012).
HIV prevalence is among the highest in Kenya, estimated at 15% in
2013 (Kenya National AIDS and STI Control Programme 2014).
Conceptual framework
As described previously, a conceptual framework identifying key
HIV policy and programmatic factors that influence HIV-related
adult mortality across the diagnosis-to-treatment continuum was de-
veloped by the ALPHA (Analysing Longitudinal and Population-
based Data on HIV in Africa) Network (Kathryn Church et al.
2015) (Figure 1). This was based on findings from a review of the lit-
erature and expert consultation to identify health systems factors
that influence access to HIV testing, treatment and retention in care.
Policy review
As outlined previously (Kathryn Church et al. 2015), Kenyan na-
tional policy documents were retrieved through internet searches
and email requests to national HIV bodies, and included if they met
the following criteria: (1) nationally relevant (not clinic or district
specific); (2) containing programmatic or clinical guidance on HIV
testing and counselling (HTC), PMTCT or HIV care and treatment
and (3) published between January 2003 and June 2013. Guideline
documents produced by WHO relevant to criteria (2) and (3) were
also retrieved. Additionally, three informal interviews were con-
ducted with Kenyan policy makers and clinicians in order to supple-
ment the national policy document review. In total 14 WHO reports
and 14 Kenyan national policy documents included content that was
Key Messages
• Kenyan national policies on HIV diagnosis, care and treatment aligned closely with recommendations from the World
Health Organization.
• In a 2013/2014 survey of rural and urban health facilities, most Kenyan national policies relating to access to ART and re-
tention in care were reported as widely implemented by facility managers, with the exception of Option Bþ for pregnant
women. However, several policies relating to HIV testing were reported to have limited implementation in both settings.
• Implementation of policies designed to facilitate diagnosis of people living with HIV was weak, and efforts are needed to
support Kenya to reach its 90-90-90 targets and move towards elimination of HIV by 2030.
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relevant to the indicators assessed in this article (see Table 1).
An Excel-based extraction tool was used to summarise information
on policy content, source, year and policy changes over time. Policy
indicators covering each of the five areas within the conceptual
framework (service access and coverage, quality of care, coordin-
ation of care and patient tracking, support to PLHIV, and medical
management, see Figure 1) were then generated. For each indicator,
Kenyan policies were categorised as being explicit, implicit, partial
(policy has caveats or exceptions), ambiguous (unclear whether pol-
icy exists, or policy conflicts with other policies) or absent.
Health facility surveys
A health facility survey questionnaire was developed as described
previously (Church et al. 2017), drawing on the conceptual frame-
work and other existing HIV health facility survey tools including
the WHO Service Availability and Readiness Assessment surveys.
The health facility surveys were carried out between October 2013
and May 2014. In Kisumu, all 34 health facilities located within the
HDSS area were surveyed. In Nairobi, where there were no formal
health facilities within the HDSS area itself, a convenience sample of
10 health facilities was taken to include different types or levels of
health facility used by HDSS residents (5 were located on the out-
skirts of the HDSS area and the other 5 were located 2–5 km away).
The survey questionnaire captured data on health facility charac-
teristics (e.g. staffing levels and client numbers), in addition to detailed
information on HTC, PMTCT and ART services as they related to the
five themes identified in the conceptual framework (Figure 1). The
questionnaire was administered in English to the staff manager at
each facility, or for some larger facilities, to the relevant staff manager
within facility sub-units. Pharmacy records and logbooks were con-
sulted to obtain accurate information on patient numbers, and drug
and test-kit availability. Data were entered into MS SQL Server
(Microsoft Corp, Redmond, USA) and exported for analysis using
Stata11 (Stata Corp, TX, USA). Descriptive statistics were used to re-
port on the provision of services according to pre-defined indicators,
grouped by the five main areas identified in the conceptual framework
as influencing the delivery of HIV services for adults.
Policy implementation analysis
We assessed policy implementation in two different analyses. For both
analyses, national policies were first classified as either explicit or not
explicit (including policies which were implicit, partial, ambiguous or
absent). In the first analysis, policy implementation was assessed in
four HIV policy areas (testing, PMTCT, access to ART and retention
in care), and analyses were broken down by HDSS site and size of facil-
ity (dispensaries and small health centres vs large health centres and
hospitals) because it was hypothesized that levels of policy implementa-
tion may vary by these factors. Policy implementation was assessed as
widespread if reported in practice in >70% of facilities (green shading
in policy implantation analysis tables); partial if reported in 30–70%
of facilities (orange shading in policy implantation analysis tables) or
limited if reported in<30% of facilities (red shading in policy implant-
ation analysis tables). The purpose of the second analysis was to assess
overall policy implementation (at both small and large health facilities)
across the five thematic areas identified in the conceptual framework
(service access and coverage, quality of care, coordination of care and
patient tracking, support to PLHIV, and medical management). In this
analysis, policy implementation at the two HDSS sites was assessed for
indicators with explicit policies only. This was in order to ease data in-
terpretation, and also because indicators with non-explicit policies had
already been assessed as part of the first analysis. A score of 1 was
Figure 1. Conceptual framework identifying health policy and service factors influencing access to HIV services across the HIV care continuum.
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assigned for limited implementation of the policy in question, 2 for
partial implementation and 3 for widespread implementation.
Ethics
Ethical approval for the health facility surveys was granted by the
authors’ institutions and ethics committees of the Kenya Medical
Research Institute (KEMRI) and the London School of Hygiene and
Tropical Medicine (LSHTM).
Results
Health facility characteristics
A summary of the characteristics of the facilities surveyed is shown
in Table 2. In Nairobi, 4 of the 10 surveyed facilities were clinics
while the remaining 6 were small or large hospitals. In Kisumu,
30 of 34 facilities surveyed were either dispensaries or small health
centres, while the remaining four facilities were either small or large
hospitals. All facilities at both sites provided HIV testing as well as
PMTCT services, while 80% (8/10) in Nairobi and 94% (32/34) in
Kisumu offered HIV care and treatment services. In terms of human
resources indicators, the median numbers of healthcare workers per
facility (as well as numbers of HIV testing clients and ART patients)
were higher in Nairobi than in Kisumu. This is likely due to the
higher proportion of larger facilities in Nairobi, and for the numbers
of healthcare workers, the relative greater availability of medical
personnel in the capital. Staff members at facilities in Kisumu had
higher patient loads (mean numbers of HIV testing clients and ART
patients per week) compared with staff members at facilities in
Nairobi (Table 2). At both sites, the patient load or burden per staff
member (number of weekly patients per clinician/nurse) was higher
for ART provision than for HIV testing service provision (while na-
tional policies recommend a maximum number of HIV testing cli-
ents (n¼15) per healthcare worker per day, there is no such
recommendation for ART clients).
A larger proportion of health facilities in Kisumu reported fre-
quent stock-outs (defined as more than one stock-out in the past
year, or a stock-out lasting >2 weeks) of HIV test kits, maternal or
infant prophylaxis for PMTCT and first line ARVs compared with
facilities in Nairobi (Figure 2). However, stock-outs of HIV test kits
were common across both sites, at both small and large health facili-
ties (50% of all facilities in Nairobi and 70% of all facilities in
Kisumu reporting frequent stock-outs).
Implementation of national HIV policies
HIV testing and counselling
Eleven indicators relating to HTC were investigated (Table 3). WHO
policies existed for 10 of these indicators, of which 8 policies were ex-
plicit. Explicit Kenyan policies existed for all 11 indicators and most
policies were reported as widely implemented across Nairobi and
Kisumu (including both small and large facilities, 8/11 policies had
wide coverage of implementation at both sites). A presidential declar-
ation in 2006 stated that all HIV related services should be provided
free of charge at government facilities, and accordingly 90% (9/10) of
facilities in Nairobi and 100% (34/34) of facilities in Kisumu reported
Table 1. Summary of WHO and Kenyan national policies relating to HIV testing and treatment
WHO policies Year
1 The Right to Know. 2003
2 Scaling up HIV Testing and Counselling Services: A Tool Kit for Programme Managers. 2004
3 UNAIDS/WHO Policy Statement on HIV Testing. 2004
4 Guidelines for Assurring the Accuracy and Reliability of HIV Rapid Testing: Applying a Quality System Approach. 2005
5 Anti-retroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach 2006
6 Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection In Infants: Towards Universal Access 2006
7 Guidance on Provider Initiated HIV Teating and Counselling in Health Facilities. 2007
8 Rapid advice: Anti-retroviral Therapy for HIV Infection in Adults and Adolescents. 2009
9 Deliver HIV Test Results and Messages for Re-testing and Counselling in Adults. 2010
10 Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. 2010
11 Antiretroviral Therapy for HIV infection in Adults and Adolescents: Recommendations for a Public Health Approach 2010
12 Guidelines for Intensified Tuberculosis Case-finding and Isoniazid Preventive Therapy for People Living with HIV in Resource-con-
strained Settings
2011
13 Program Update: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. 2012
14 Consolidated Guidelines on the Use of Anti-retroviral Drugs for Treating and Preventing HIV Infection 2013
Kenya Policies Year
15 National ART Guidelines. NASCOP. 2005
16 National ART Guidelines. NASCOP. 2006
17 Presidential Declaration. 2006
18 Guidelines for HIV Testing and Counselling in Kenya. NASCOP. 2007
19 Kenya National Clinic Manual for ART Providers. NASCOP. 2007
20 Presidential Declaration. 2007
21 Guidelines for HIV Testing and Counselling in Kenya. NASCOP. 2008
22 National Guidelines for HIV/STI Programs for Sex Workers. MoPHS. 2010
23 National Recommendations for PMTCT of HIV, IYCF, and ART Therapy for Children, Adults, and Adolescents. MoPHS &
MMS.
2010
24 National Quality Management Guidance Framework for HIV Testing and Counselling. NASCOP. 2010
25 Repeat and Re-testing Guidance. NASCOP. 2010
26 Guidelines for Antiretroviral Therapy in Kenya. NASCOP. 2011
27 Operational Manual for Community Based Testing for HIV Testing and Counselling. NASCOP. 2012
28 Guidelines for PMTCT of HIV/AIDS in Kenya. NASCOP. 2012
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offering free HTC (Table 3) (even though only 60% and 88% of
facilities were government-run in Nairobi and Kisumu, respectively).
In addition, national quality management guidance stated that HIV-
positive clients should be followed-up when referred for treatment,
and 80% (8/10) and 97% (33/34) of facilities in Nairobi and Kisumu
respectively reported having procedures to check whether HIV-
positive patients had registered in care.
However, there was partial or limited implementation of some
HTC indicators despite the existence of explicit national policy.
For example, increasing HTC for high risk groups was highlighted as
a priority area in the Kenya National AIDS Strategic Plan 2009/10-
2012/13, and national guidelines state that vulnerable populations
such as MSM, CSW and IDU should be provided with tailored and
equitable access to HTC. Overall 70% of facilities in Nairobi reported
offering HTC to high-risk groups (75% (3/4) of small facilities and
67% (4/6) of large facilities). However in Kisumu, only 20% (6/30) of
small facilities reported offering HTC to high risk groups while 75%
(3/4) of large facilities reported doing so (Table 2).
Other HTC policies which were explicit but had partial or lim-
ited implementation included a policy stating counsellors should re-
ceive no>15 clients per day (implemented at 70% (7/10) of Nairobi
clinics and 50% (14/34) of Kisumu clinics), quality of care reviews
to be conducted twice per year (wide implementation in Kisumu
[74% of facilities] but only partial implementation in Nairobi [50%
of facilities]) and repeat testing for pregnant women in their third
trimester (wide implementation in Nairobi [90% of facilities] but
only partial implementation in Kisumu [47% of facilities]).
PMTCT
Seven indicators relating to PMTCT were investigated (Table 4).
Explicit WHO policies existed for three of these indicators, while ex-
plicit Kenyan national policies existed for only two indicators.
Despite this, widespread implementation of most indicators relating
to PMTCT was reported. For example, 80% (8/10) and 91% (31/34)
of facilities in Nairobi and Kisumu reported always providing
PMTCT drugs for HIV-positive women who wanted or were likely
to deliver at home despite the lack of an explicit national policy. One
exception related to implementation of Option Bþ. While policy
Table 2. Summary characteristics of surveyed facilities in Kisumu and Nairobi
Nairobi Kisumu
Total number of clinics, n(%) 10 (100) 34 (100)
Type of facility
Dispensary/small health centre 4 (40) 30 (88)
Large health centre/sub-district hospital 4 (40) 3 (9)
District/referral hospital 2 (20) 1 (3)
Management authority, n (%)
Government 6 (60) 30 (88)
Faith-based organisation 3 (30) 3 (9)
Other NGO 1 (10) 0 (0)
Private-for-profit 0 (0) 1 (3)
HIV-related services, n (%)
HIV testing 10 (100) 34 (100)
PMTCT 10 (100) 34 (100)
HIV care (incl. pre-ART) 8 (80) 32 (94)
HIV treatment 8 (80) 32 (94)
Human resources and patient load, median (range)
No. of cliniciansa 2.5 (0.0–8.0) 1 (0–34.5)
No. nurses/midwives 6.5 (0–18.0) 2 (0–62.0)
No. counsellors 2 (0–13.0) 0.3 (0–7.0)
No. HIV testing clients/week 78 (11.0–1237.0) 39 (0–206.0)
No. weekly HIV testing clients/staffb 1.3 (0.8–42) 3.7 (0–41.2)
Staff turnoverc 11 (0–87.0) 0 (0–170.0)
Human resources for ART - clinics offering ART
No. ART clients/week (median (range)) 50 (35–141.0) 37 (0–154.0)
No. weekly ART clients/clinician or nurse (median (range)) 4.8 (3.3–8.8) 11.7 (0–25.0)
Facilities with clinician, n (%) 7 (88) 25 (78)
Facilities with lab technician, n (%) 7 (88) 17 (53)
aDoctor, clinical officer, assistant medical officer.
bNurse, midwife, nursing aide, counsellor or community outreach worker.
cNo. staff left in past year/total staff (nurses, clinicians, aides, counsellors, outreach), as a percentage.
Figure 2. Percentage of facilities with frequent* stock-outs of HIV test-kits and
treatment. *More than one in past year, or a stock-out lasting more than
2weeks. **Opportunistic infection prophylaxis
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recommended that lifelong ART should be initiated in pregnant
women as soon as possible, it was stated that provision of Option Bþ
should be limited to facilities with capacity to initiate this. Reported
implementation of Option Bþ was limited, with only 20% of
Nairobi clinics (no small facilities and 33% (2/6) of large facilities)
and 6% of Kisumu clinics (3% (1/30) of small facilities and 25%
(1/4) of large facilities) reporting offering this as the standard of care
for HIV-positive pregnant women (Table 4).
Table 3. Implementation of policies relating to HIV testing and counselling
WHO policy
(year of policy)a
Kenyan policy
(year of policy)a
NAIROBI KISUMU
Small
facilities
(n ¼ 4)
Large
facilities
(n ¼ 6)
Small
facilities
(n ¼ 30)
Large
facilities
(n ¼ 4)
Service access and coverage (%)
Free testing at public facilities 20031 200617 75 100 100 100
PITC for ANC clients 20043 200718 100 100 87 100
HTC for high-risk groups 20043 201022 75 67 20 75
Quality of care (QoC) (%)
Max 15 clients/day/counsellor None 201227 75 67 53 25
QoC reviews at least twice/year 20054 201024 25 67 73 75
Coordination of care and patient tracking (%)
HIV- re-test every 6-12 months 20077 201025 100 67 100 75
Repeat testing in 3rd trimester 20109 201023 100 83 43 75
Check if HIVþ register at treatment site 20042 201024 75 83 97 100
Support to PLHIV (%)
HTC pre-test counselling always given 20031 200821 100 100 90 100
HTC post-test counselling always given 20031 200821 75 100 97 100
Couples HTC offered 20042 200821 100 83 67 100
KEY
WHO/Kenyan National Policies
Explicit policy
No explicit policy (i.e. policy implicit, partial, ambiguous or absent)
Kenya policy implementation analysis:
Explicit policy, wide implementation
No explicit policy, wide implementation
Explicit policy, partial implementation
No explicit policy, partial implementation
Explicit policy, limited implementation
No explicit policy, limited implementation
aSuperscript numbers relate to policy document reference number as listed in Table 1.
Table 4. Implementation of policies relating to PMTCT
WHO policy
(year of guideline)a
Kenyan
policy (year of policy)a
NAIROBI KISUMU
Small
facilities
(n ¼ 4)
Large
facilities
(n ¼ 6)
Small
facilities
(n ¼ 30)
Large
facilities
(n ¼ 4)
Service access and coverage (%)
PMTCTb available 201010 201228 75 100 100 100
Free PMTCT at public facilities Universal access 200617 50 83 100 100
Quality of care (QoC) (%)
QoC reviews at least once/year None None 75 100 93 100
Coordination of care and patient tracking (%)
PMTCT drugs always given for home delivery None None 75 83 97 50
Mothers referred for ART (during ANC/1 mo post-birth) 20066 201228 100 100 83 75
Check if mother registers for treatment None None 75 100 100 100
Medical management (%)
Option Bþ is standard 201213 201228 0 33 3 25
aSuperscript numbers relate to policy document reference number as listed in Table 1.
bProphylaxis or treatment for mother plus prophylaxis for baby.
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HIV care and treatment
Eight indicators in relation to HIV care and treatment were assessed
(Table 5). WHO policies existed for five of these indicators, of
which three policies were explicit and two policies were partial or
had caveats (left to countries to decide). At the Kenyan national
level, policy adoption as well as implementation was reported as
strong (six indicators with explicit policy and two without explicit
policy). For six of eight indicators, implementation across both sites
was reported to occur at 100% of facilities, including provision of
free ART, allowing ART initiation by lower cadre health workers
(clinical officers or nurses), being able to initiate ART within the
ART clinic, conducting 6-monthly CD4 tests in the pre-ART phase,
recording pre-ART visits on computers or patient registers, and ena-
bling all patients with tuberculosis to initiate ART. Policy stated
that laboratory tests such as renal or liver function tests were desir-
able but not a prerequisite for ART initiation. In practice, few facili-
ties at either site reported initiating ART without any such tests
(12.5% [1/8] of Nairobi clinics and 31% [10/32] of Kisumu clinics).
Retention in care
Fifteen indicators relating to retention in HIV care were assessed
(Table 6). WHO policies existed for eight of these indicators, of
which seven policies were explicit and one policy was implicit. At
the Kenyan national level, explicit policies existed for 11 of the 15
indicators. Implementation of policies generally appeared stronger
in Kisumu than Nairobi: all explicit policies were reported as widely
implemented in Kisumu for both large and small facilities, whereas
in Nairobi four explicit policies had only partial implementation
coverage. Implementation was strong for two service indicators that
had no explicit policy (for example, 100% [8/8] of Nairobi facilities
and 94% [30/32] of Kisumu facilities reported providing home-
based care for patients on ART). All facilities in both Nairobi and
Kisumu provided at least one WHO recommended first line ART
regimen according to 2010 guidelines (i.e. a TDF or AZT-based regi-
men—recalling that the health facility surveys were conducted in
2013/2014), while 88% (7/8) of Nairobi clinics and 75% (24/32) of
Kisumu clinics reported offering at least four different first-line regi-
mens. Policies relating to support to PLHIV were well implemented.
For example 100% of facilities in both sites reported both peer sup-
port and nutritional support for patients on ART. Some indicators
in relation to coordination of care were less well implemented in
Nairobi facilities compared with Kisumu. For example, policy rec-
ommended that routine pill counts be conducted at every ART visit,
but only 63% (5/8) of Nairobi facilities reported conducting these
compared with 78% (25/32) of Kisumu facilities.
Summarising policy implementation across the themes
in the conceptual framework
Across the five themes identified in the conceptual framework, there
was generally widespread implementation (>70% of facilities imple-
menting – score of 3) of indicators with explicit policies (Figure 3
shows results for themes ‘service access and coverage’, ‘quality of
care’ and ‘coordination of care and patient tracking’. For themes
‘support to PLHIV’ and ‘medical management’, there was wide-
spread implementation of all indicators with explicit policy).
Themes with the largest proportions of indicators without explicit
policy (indicators not shown in Figure 3) included (1) coordination
of care and patient tracking and (2) medical management (non-ex-
plicit policies for 5/16 [31%] and 2/7 [29%] of indicators, respect-
ively). Despite this, implementation of indicators relating to
coordination of care was usually strong, even where policy was not
explicit. For medical management, policy regarding Option Bþ was
not explicit, and implementation was limited.
Discussion
We identified a close alignment between Kenyan national policies
on HIV care and treatment and guidelines produced by the WHO,
with a few instances of policy gaps in the areas of PMTCT, access to
ART and retention in care. We also found that national policies
were generally reported as widely implemented in Nairobi as well as
Kisumu, and in both large and small facilities, with the exception of
Option Bþ (limited implementation) as well as limited of some ex-
plicit policies relating to HIV testing and counselling. The provision
of HTC for high-risk groups was particularly poor, with only 9/34
(27%) facilities in Kisumu offering tailored HTC for CSW, MSM
and IDUs. This contrasts with a call within the National Strategic
Plan to increase access to HTC among MARPs in addition to the
general population (National AIDS Control Council 2014b). It is
worth noting however, that there was some level of support for this
Table 5. Implementation of policies relating to HIV care and treatment
WHO policy
(year of guideline)a
Kenyan policy
(year of policy)a
NAIROBI KISUMU
Small
facilities
(n ¼ 2)
Large
facilities
(n ¼ 6)
Small
facilities
(n ¼ 28)
Large
facilities
(n ¼ 4)
Service access and coverage (%)
Free ART at public facilities Universal access 201126 100 100 100 100
ART initiation by clinical officers or nurses None 200515 100 100 100 100
ART initiation in all ART clinic None None 100 100 100 100
Coordination of care and patient tracking (%)
6 monthly CD4 testing in pre-ART phase None 201126 100 100 100 100
Pre ART visits recorded (e.g. computer, register, card) Left to country 201126 100 100 100 100
Medical management (%)
Initiate ART at WHO Stage 3/4 or CD4350 20098 201126 100 83 100 75
Lab tests not required to start ART Recommended 200616 50 0 32 25
All patients with TB eligible for ART 20098 200719 100 100 100 100
aSuperscript numbers relate to policy document reference number as listed in Table 1.
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activity, which is not seen in other countries that do not specifically
recognise these groups in their policy documents, such as Uganda
(Kathryn Church et al. 2015). Epidemiological data indicating that
infection is concentrated among MARPs in Kenya provide further
support for the need to strengthen testing for these groups so that
they may enter care at the earliest opportunity (Brodish et al. 2011;
Muraguri et al. 2015; Musyoki et al. 2015). This is also of import-
ance given the reported rise in injecting drug use across East Africa
(Beckerleg et al. 2005).
There were gaps in the adoption of some policies relating to
PMTCT (Option Bþ as standard, PMTCT drugs always given for
home deliveries, mothers referred for treatment during ANC or
within one month after delivery, check if mother registers for treat-
ment). Despite this, implementation was nevertheless reported as
widespread at both sites for many indicators. This may reflect the in-
fluence of international organisations and the release of guidance
from the WHO on PMTCT in 2013, or autonomous actions of
facilities run by non-governmental organisations. There was a cav-
eat to the Option Bþpolicy in Kenya, which stated this was recom-
mended only at sites with the capacity to initiate this.
Implementation of Option Bþwas very limited (20% of clinics in
Nairobi and 6% in Kisumu), which could be a marker of the per-
ceived readiness of facilities to take on the additional long-term pa-
tient load and burden that would arise from complete adoption of
Option Bþ. However given current WHO guidance, rapid expan-
sion of Option Bþ should be considered a programme priority in
Kenya. An updated policy review and second round of facility sur-
veys are being undertaken, and it will be interesting to see if imple-
mentation of Option Bþhas changed or improved over time.
One policy influencing entry into care that was only widely im-
plemented in Nairobi, but not Kisumu, was repeat testing of preg-
nant women in their third trimester. HIV testing and PMTCT are
both key gateways to HIV care and ART, and should thus be a focus
area for the Kenyan government if they hope to meet the 90-90-90
targets by 2020 (UNAIDS 2014b). Although facilities appeared to
be offering many PMTCT services, despite lack of explicit policy,
there is still a need for clear recommendations relating to testing of
pregnant women and initiation onto ART from the Ministry of
Health, in order to gain further traction and for revisions to alloca-
tion of resources. Antenatal and ART clinics will require significant
investment and support in order to help them cope with increasing
patient loads as a result of Option Bþ.
Policy adoption and implementation in relation to ART access
and retention in care was strong in both rural and urban sites in this
study. However in 2015 the WHO released guidance recommending
ART initiation as soon as possible after diagnosis for all HIV-
positive individuals, regardless of CD4 count, which is likely to put
additional strain on HIV services (World Health Organisation
2015). At health facilities in both Kisumu and Nairobi, ART patient
loads (number of weekly patients per clinician/nurse) were already
higher at ART clinics than at HIV testing clinics, and so investments
in human resources as well as task-shifting to lower cadre healthcare
workers and/or use of alternative strategies for ART delivery will be
required to support the move towards test and treat, if this is
adopted as national level policy. The majority of health facilities at
both sites required at least some lab tests before ART initiation (usu-
ally renal or liver function tests, or haemoglobin counts), and this
may also prove challenging in terms of workload if test and treat
strategies are adopted (Nachega et al. 2014). Another area of con-
cern at both sites related to stock-outs of HIV test kits (frequent
stock-outs reported at 70% and 50% of facilities in Kisumu and
Nairobi respectivelyStock-outs of ART and other prophylactic drugs
were less common. Further investigation at the sites would be
needed to understand what factors enable smooth provision of HIV
test kits and some medications over others. It is likely that the lower
proportion of facilities reporting stock-outs in Nairobi compared
with Kisumu is related to distance from central supply stores, how-
ever, reliable supply chains across the whole country and along the
Table 6. Implementation of policies relating to retention in care
WHO policy
(year of guideline)a
Kenyan policy
(year of policy)a
NAIROBI KISUMU
Small
facilities
(n ¼ 2)
Large
facilities
(n ¼ 6)
Small
facilities
(n ¼ 28)
Large
facilities
(n ¼ 4)
Quality of care (%)
Periodic checks on QoC at ART clinic 201011 201126 100 100 96 100
Coordination of care and patient tracking (%)
6 monthly CD4 counts when on ART Not required 200515 100 80 96 100
3 monthly drug supplies once stable on ART None 201126 50 67 79 75
Routine pill counts once on ART? None 200515 50 67 75 100
Home visits following poor adherence None None 0 17 32 50
Home/phone contact following missed visit 201314 201126 100 100 96 100
Drugs collectable by designee None None 50 100 100 100
TB services integrated in facility 201112 200515 100 100 100 100
Support to PLHIV (%)
Adherence counselling required None 200515 100 100 100 100
Peer support for people on ART None 201126 100 100 100 100
Nutritional support for people on ART 20065 200515 100 100 100 100
Home-based care for people on ART None None 100 100 93 100
Medical management (%)
TB screen at every ART visit 201112 200515 100 100 100 100
WHO 1st line (2010) as standard 201011 201126 100 100 100 100
At least four first-line regimens available 20065 201126 50 100 75 75
aSuperscript numbers relate to policy document reference number as listed in Table 1.
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care continuum are required in order to meet 90-90-90 targets and
maximise the effectiveness of HIV service provision.
The finding that policy implementation was widest in relation to
treatment and retention in care, and poorer for HIV testing and
PMTCT, contrasts with the situation in other settings. In Malawi,
emphasis has been on implementation of policies to promote rapid
initiation of ART, with weaker implementation of strategies to pro-
mote retention in care (e.g. adherence monitoring, home-based care)
(Dasgupta et al. 2016). A similar finding has been reported for
Uganda where policy adoption and implementation have been pro-
gressive for HIV testing, treatment, and PMTCT, but often lacking
in relation to retention in care (McRobie et al. 2015). Further quali-
tative investigation might help to draw out the possible barriers or
facilitating factors to policy adoption in different areas across differ-
ent settings.
In terms of the themes identified in the conceptual framework,
there was no single domain that stood out as particularly weak in
terms of policy implementation across the different areas of service
delivery that we investigated. For the themes relating to support to
PLHIV and medical management, scores were high for all indicators
with explicit policies. This is encouraging given the current nature of
HIV as a chronic condition requiring long-term management and
care.
There are some limitations that need to be considered when in-
terpreting the findings from this study. First, health facility attri-
butes and practices were reported by staff and may have been
subject to reporting bias, resulting in a more positive picture of pol-
icy implementation than is the reality. Second, the health facilities
surveyed were those serving the populations at the HDSS sites
Nairobi and Kisumu, and were not selected to be representative of
Figure 3. Policy implementation analysis by indicators influencing access to HIV services (indicators with explicit policy)
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all HIV clinics in the country. Nevertheless, the clinics do not receive
additional interventions or support as a result of the HDSS activities,
and can therefore be considered as fairly typical of the services that
are available to these populations.
Conclusions
Targeting policy implementation gaps identified by this study, not-
ably those relating to HIV testing and implementation of Option
Bþ, would help Kenya to reach the ambitious 90-90-90 targets by
2020. Smaller health facilities are likely to require additional sup-
port to implement test and treat strategies once these are adopted as
national level policy.
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